T cell defined tumor antigens - PubMed (original) (raw)
Review
T cell defined tumor antigens
B J Van den Eynde et al. Curr Opin Immunol. 1997 Oct.
Abstract
T cell defined antigens have now been characterized in a large variety of tumor types, in both mice and humans. An increasing number of these antigens appear to result from tumor-specific mutations, and some of these mutations may be implicated in oncogenesis. The priority is now to demonstrate that immunization against some of these antigens is clinically valuable for antitumor therapy, and the first results of clinical pilot studies are now emerging.
Similar articles
- [Tumor antigens recognized by T-lymphocytes in human cancers. New advances and therapeutic perspectives].
Gaugler B, Olive D. Gaugler B, et al. Pathol Biol (Paris). 1998 Dec;46(10):771-8. Pathol Biol (Paris). 1998. PMID: 9922993 Review. French. - The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection.
Brändle D, Bilsborough J, Rülicke T, Uyttenhove C, Boon T, Van den Eynde BJ. Brändle D, et al. Eur J Immunol. 1998 Dec;28(12):4010-9. doi: 10.1002/(SICI)1521-4141(199812)28:12<4010::AID-IMMU4010>3.0.CO;2-5. Eur J Immunol. 1998. PMID: 9862337 - T cells must recognize tumor antigen in association with self-MHC antigen.
Lannin DR, Yu S, McKhann CF. Lannin DR, et al. Transplant Proc. 1981 Mar;13(1 Pt 2):739-41. Transplant Proc. 1981. PMID: 6168072 No abstract available. - A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells.
Lucas S, Brasseur F, Boon T. Lucas S, et al. Cancer Res. 1999 Aug 15;59(16):4100-3. Cancer Res. 1999. PMID: 10463614 - Hitting the Target: How T Cells Detect and Eliminate Tumors.
Zamora AE, Crawford JC, Thomas PG. Zamora AE, et al. J Immunol. 2018 Jan 15;200(2):392-399. doi: 10.4049/jimmunol.1701413. J Immunol. 2018. PMID: 29311380 Free PMC article. Review.
Cited by
- Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.
Kessler JH, Beekman NJ, Bres-Vloemans SA, Verdijk P, van Veelen PA, Kloosterman-Joosten AM, Vissers DC, ten Bosch GJ, Kester MG, Sijts A, Wouter Drijfhout J, Ossendorp F, Offringa R, Melief CJ. Kessler JH, et al. J Exp Med. 2001 Jan 1;193(1):73-88. doi: 10.1084/jem.193.1.73. J Exp Med. 2001. PMID: 11136822 Free PMC article. - Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models.
Corthay A, Lundin KU, Munthe LA, Frøyland M, Gedde-Dahl T, Dembic Z, Bogen B. Corthay A, et al. Cancer Immunol Immunother. 2004 Sep;53(9):759-69. doi: 10.1007/s00262-004-0504-1. Epub 2004 Apr 15. Cancer Immunol Immunother. 2004. PMID: 15088126 Free PMC article. Review. - Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.
Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD. Yee C, et al. Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16168-73. doi: 10.1073/pnas.242600099. Epub 2002 Nov 11. Proc Natl Acad Sci U S A. 2002. PMID: 12427970 Free PMC article. Clinical Trial. - CD8+ T Cell Responses during HCV Infection and HCC.
Hofmann M, Tauber C, Hensel N, Thimme R. Hofmann M, et al. J Clin Med. 2021 Mar 2;10(5):991. doi: 10.3390/jcm10050991. J Clin Med. 2021. PMID: 33801203 Free PMC article. Review. - Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma.
Peña-Asensio J, Calvo H, Torralba M, Miquel J, Sanz-de-Villalobos E, Larrubia JR. Peña-Asensio J, et al. Cancers (Basel). 2021 Apr 16;13(8):1922. doi: 10.3390/cancers13081922. Cancers (Basel). 2021. PMID: 33923463 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources